Emerald Advisers’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Emerald Advisers’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,896	Closed	-$1.12M	–	299
2021 Q4	$1.12M	Sell	10,896 -243	-2%	-$23.3K	0.04%	159
2021 Q3	$974K	Sell	11,139 -2,884	-21%	-$261K	0.04%	156
2021 Q2	$1.25M	Buy	14,023 +770	+6%	+$65.1K	0.05%	144
2021 Q1	$1M	Sell	13,253 -590	-4%	-$44.5K	0.04%	149
2020 Q4	$943K	Buy	13,843 +2,595	+23%	+$162K	0.03%	156
2020 Q3	$598K	Buy	11,248 +1,980	+21%	+$118K	0.02%	172
2020 Q2	$540K	Buy	+9,268	New	+$498K	0.02%	177
2015 Q1	–	Sell	-124,795	Closed	-$3.21M	–	368
2014 Q4	$3.21M	Buy	+124,795	New	+$2.97M	0.17%	157

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Emerald Advisers's SYNH Position: Q1 2022 in Review

Emerald Advisers sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022, closing a stake of 10,896 shares — an estimated $1.12M sold.

Emerald Advisers first reported a position in SYNH in Q4 2014 and held it in 8 quarters. The position peaked at $3.21M in Q4 2014. 366 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

Emerald Advisers reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
Emerald Advisers sold 10,896 Syneos Health, Inc. Class A Common Stock shares in Q1 2022, an estimated $1.12M.
Emerald Advisers first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2014 and held it in 8 quarters.
Emerald Advisers's Syneos Health, Inc. Class A Common Stock position peaked at $3.21M in Q4 2014.
366 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Emerald Advisers's 13F filing for Q1 2022, filed 29 Apr 2022.